EPP and Alliance Life Sciences join forces : because changing times ask for solid pricing!

As the life sciences industry faces unprecedented market changes that are pushing manufacturers to adapt their strategies and business models, many are investing in building capabilities to help them meet commercial and strategic objectives.  
The European Pricing Platform® and forum partner Alliance Life Sciences present the 5th EPP Life Sciences Pricing Forum, 21-23, September, Montreux, Switzerland -- the only event of its kind dedicated entirely to life sciences. 
“All pricing professionals need to realise they are not alone in their situation,” says Pol Vanaerde, founder of EPP.  “Many companies have already tackled these same challenges.  The main idea of this EPP Forum is for companies to inspire each other and look for innovative solutions to real-life challenges. At the EPP, we do not believe in a general plan of solutions, but a concrete, ready-to-use action plan for everyone”.

Delegates from across the spectrum of pharma, generics and medical technology will come together to share, discuss and debate the best approaches to optimising pricing and profitability management. 

Influential industry professionals will have the opportunity to meet senior pricing practitioners and experts to discuss the recent evolution within the pricing and profit optimisation sector. 

The event offers pre-forum workshops and over 25 industry-leading speakers, including representatives from the MPS Society, HTAs from across Europe, and pricing-and-market experts from Boston Scientific, Novartis, Philips Healthcare, Celgene, Takeda Pharmaceuticals and others. 

The forum focuses on the industry's need to optimise price, profit and revenue life cycle processes ranging from strategy to planning and execution.
More than ever, the industry must rely upon advanced solutions and knowledge management to meet today’s current challenges says Alan Crowther, CEO, Alliance Life Sciences, who serves on the EPP steering committee. 

We share EPP’s vision to enhance price optimisation in the global life sciences marketplace, and understand the significant level of complexity created by diverse processes across different countries. We are excited to be a part of this innovative event and are looking forward to exchanging ideas with other pricing professionals.”
To ensure maximum relevance for everyone, several “sector track sessions” are offered for medtech or pharma-generics professionals and their pricing and profit optimisation challenges.

This year, coordinators offer reservations for the 22 of September for a wine tasting and presentation of the UNESCO Lavaux wine region before going to dinner at Le Relais de la Poste, where participants will enjoy a delicious dinner with plenty of informal networking opportunities.

For more information on the 5th EPP Life Sciences Pricing Forum or to register, go to:

Press contact: Britt Dejager - Project Manager - EPP                           
M    +32/473.717.669 Tel  +32/ - Fax +32/               

About The European Pricing Platform (EPP) - Connecting Pricing and Profit Optimisation Management around the globe:

The European Pricing Platform is the #1 pricing and profit optimisation organisation with the mission to help develop both personal and organisational pricing maturity. www.pricingplatform.eu

Press contact Morayéa K. Pindziak | Vice President, Marketing – Alliance Life Sciences
Office: 908.947.4115 | Cell: 267.760.2694 | morayea.pindziak@alscg.com  | www.alscg.com  

About Alliance Life Sciences
Alliance Life Sciences is a global innovator that delivers peace of mind and unlocks business value with unique solutions to complex commercial problems. With over ten years of dedicated life sciences experience, our worldwide team of experts provides insights into contracting, pricing, and access. We serve mid-market life sciences companies and eight of the top-10 pharmaceutical manufacturers and multiple medical device and diagnostic firms. Contact: 866.581.4850 or www.alscg.com.